Jefferies Cuts Target on Vivus (VVUS) after FDA CV Panel, Keeps Lowest Rating
Tweet Send to a FriendGet Alerts VVUS Hot Sheet
Price: $13.52 +2.74%
Rating Summary:
6 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 28 | New: 14
Rating Summary:
6 Buy, 6 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 28 | New: 14
Trade VVUS Now!
Jefferies cuts its price target on Vivus (NASDAQ: VVUS) from $12 to $9 after yesterday's FDA CV panel.
The firm comments, "In spite of an unfavorable FDA panel vote recommending combined pre- and post-approval CV safety analyses even for obesity drugs without a theoretical risk of CV harm, after-market VVUS stock price indications still reflect strong optimism around approval. We remain cautious on the bull argument for several reasons outlined below and see a significant risk that Qnexa is subject to additional CV risk evaluation prior to approval."
For an analyst ratings summary and ratings history on Vivus click here. For more ratings news on Vivus click here.
Shares of Vivus closed at $21.28 yesterday, with a 52 week range of $6.11-$25.14.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm comments, "In spite of an unfavorable FDA panel vote recommending combined pre- and post-approval CV safety analyses even for obesity drugs without a theoretical risk of CV harm, after-market VVUS stock price indications still reflect strong optimism around approval. We remain cautious on the bull argument for several reasons outlined below and see a significant risk that Qnexa is subject to additional CV risk evaluation prior to approval."
For an analyst ratings summary and ratings history on Vivus click here. For more ratings news on Vivus click here.
Shares of Vivus closed at $21.28 yesterday, with a 52 week range of $6.11-$25.14.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- KeyBank Upgrades MDC Holdings (MDC); Cuts PulteGroup (PHM) & Ryland Group (RYL)
- NetApp (NTAP) Post Solid Q4, Numbers Bumped - Needham & Company
- Dougherty & Co Raises PT on SodaStream (SODA) to $80
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT Change, FDARelated Entities
Jefferies & Co
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
